Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors

Bayyurt, 2017, Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development, J. Control Release, 247, 134, 10.1016/j.jconrel.2017.01.004 Bode, 2011, CpG DNA as a vaccine adjuvant, Expert Rev. Vaccines, 10, 499, 10.1586/erv.10.174 Boehm, 2013, In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction, Mediators Inflamm., 2013, 10.1155/2013/217297 Brito, 2014, Designing and building the next generation of improved vaccine adjuvants, J. Control. Release, 190, 563, 10.1016/j.jconrel.2014.06.027 De Waele, 2018, Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade, Oncoimmunology, 7, 10.1080/2162402X.2017.1407899 Delany, 2014, Vaccines for the 21st century, EMBO Mol. Med., 6, 708, 10.1002/emmm.201403876 Dooling, 2018, Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines, MMWR Morb. Mortal. Wkly Rep., 67, 103, 10.15585/mmwr.mm6703a5 Duewell, 2011, ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of, J. Immunol., 187, 55, 10.4049/jimmunol.1004114 Eng, 2013, The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV review, Hum Vaccin Immunother, 9, 1661, 10.4161/hv.24715 Esser, 2003, Memory and vaccines, Vaccine, 21, 419, 10.1016/S0264-410X(02)00407-3 Frampton, 2018, Molecular signatures of regression of the canine transmissible venereal tumor, Cancer Cell, 33 Hafner, 2011, Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling, Biomaterials, 32, 2651, 10.1016/j.biomaterials.2010.12.021 Ito, 2017, IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model, Cancer Immunol. Immunother., 66, 1485, 10.1007/s00262-017-2043-6 Jackson, 2018, Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults, Vaccine, 36, 668, 10.1016/j.vaccine.2017.12.038 Jain, 2015, Formulation and stabilization of recombinant protein based virus-like particle vaccines, Adv. Drug Deliv. Rev., 93, 42, 10.1016/j.addr.2014.10.023 Kanchan, 2009, Memory antibody response from antigen loaded polymer particles and the effect of antigen release kinetics, Biomaterials, 30, 4763, 10.1016/j.biomaterials.2009.05.075 Kaparakis-Liaskos, 2015, Immune modulation by bacterial outer membrane vesicles, Nat. Rev. Immunol., 15, 375, 10.1038/nri3837 Kurts, 2010, Cross-priming in health and disease, Nat. Rev. Immunol., 10, 403, 10.1038/nri2780 Lam, 2018, Emergence of CD4+ and CD8+ polyfunctional responses against immunodominant lytic and latent EBV antigens in children with primary EBV infection, Front. Microbiol., 9, 416, 10.3389/fmicb.2018.00416 Lim, 2015, Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease, Clin. Exp. Vaccine Res., 4, 54, 10.7774/cevr.2015.4.1.54 Liu, 2018, Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model, Hum Vaccin Immunother, 14, 931, 10.1080/21645515.2017.1420446 Liu, 2015, Production of recombinant human papillomavirus type 52 L1 protein in Hansenula polymorpha formed virus-like particles, J. Microbiol. Biotechnol., 25, 936, 10.4014/jmb.1412.12027 Liu, 2016, Hyaluronic Acid-modified cationic lipid-PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses, ACS Appl. Mater. Interfaces, 8, 11969, 10.1021/acsami.6b01135 Liu, 2016, Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles, J. Control. Release, 225, 230, 10.1016/j.jconrel.2016.01.050 Maurer, 2002, CpG-DNA aided cross-presentation of soluble antigens by dendritic cells, Eur. J. Immunol., 32, 2356, 10.1002/1521-4141(200208)32:8<2356::AID-IMMU2356>3.0.CO;2-Z Muller, 2006, Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors, Nat. Rev. Cancer, 6, 613, 10.1038/nrc1929 Mutwiri, 2004, Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides, J. Control Release, 97, 1, 10.1016/j.jconrel.2004.02.022 Olive, 2012, Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants, Expert Rev. Vaccines, 11, 237, 10.1586/erv.11.189 Ott, 2017, An immunogenic personal neoantigen vaccine for patients with melanoma, Nature, 547, 217, 10.1038/nature22991 Platt, 2013, Innate immunity and vaccines, Curr. Top. Med. Chem., 13, 2597, 10.2174/15680266113136660185 Reed, 2013, Key roles of adjuvants in modern vaccines, Nat. Med., 19, 1597, 10.1038/nm.3409 Reinis, 2010, Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines, Int. J. Oncol., 36, 545, 10.3892/ijo_00000528 Rosenthal, 2014, Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale, Curr. Opin. Biotechnol., 28, 51, 10.1016/j.copbio.2013.11.005 Schnurr, 2009, ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II, J. Immunol., 182, 1253, 10.4049/jimmunol.182.3.1253 Schulz, 2005, Toll-like receptor 3 promotes cross-priming to virus-infected cells, Nature, 433, 887, 10.1038/nature03326 Wu, 2016, CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage, Life Sci., 161, 51, 10.1016/j.lfs.2016.07.016 Yamamoto, 2009, Synthetic oligodeoxynucleotides induce gastritis in mice, Fukushima J. Med. Sci., 55, 23, 10.5387/fms.55.23 Zhang, 2013, Gene transfection efficacy and biocompatibility of polycation/DNA complexes coated with enzyme degradable PEGylated hyaluronic acid, Biomaterials, 34, 6495, 10.1016/j.biomaterials.2013.04.030 Zhang, 2014, Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation, Biomaterials, 35, 6086, 10.1016/j.biomaterials.2014.04.022 Zhang, 2016, A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies, Virology, 489, 165, 10.1016/j.virol.2015.10.029 Zhong, 2010, Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes, J Nanobiotechnology, 8, 6, 10.1186/1477-3155-8-6 Zhu, 2010, Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice, J Clin Invest, 120, 607, 10.1172/JCI39293 Zhu, 2008, Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines, Proc Natl Acad Sci U S A, 105, 16260, 10.1073/pnas.0805325105 Zitvogel, 2006, Cancer despite immunosurveillance: immunoselection and immunosubversion, Nat. Rev. Immunol., 6, 715, 10.1038/nri1936